Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Efficacy and Safety of Baricitinib in Patients with Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic DMARDs and/or Biological DMARDs: Data from a Local Registry
José Rosas; José Miguel Senabre-Gallego; Gregorio Santos-Soler; José Antonio Bernal; Ana Pons Bas;
Reumatol Clin. 2022;18:188-9
Clinical management and discontinuation of treatment in patients with recent onset rheumatoid arthritis in a rheumatology consultation
Zulema Rosales Rosado; Judit Font Urgelles; Isabel Hernández Rodríguez; Leticia León Mateos; Lydia Abásolo Alcázar; Juan Ángel Jover Jover;
Reumatol Clin. 2022;18:77-83
Effectiveness, safety and economic analysis of Benepali in clinical practice
Marta Rojas-Giménez; Natalia Mena-Vázquez; Carmen María Romero-Barco; Sara Manrique-Arija; Inmaculada Ureña-Garnica; Gisela Diaz-Cordovés; Francisco Gabriel Jiménez-Núñez; Antonio Fernández-Nebro;
Reumatol Clin. 2021;17:588-94